Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.
2.

Clinical features of Parkinson's disease patients are associated with therapeutic misconception and willingness to participate in clinical trials.

Reijula E, Pietilä AM, Halkoaho A, Selander T, Martikainen K, Kälviäinen R, Keränen T.

Trials. 2017 Sep 29;18(1):444. doi: 10.1186/s13063-017-2174-2.

3.

A study of motivations and expectations of patients seen in phase 1 oncology clinics.

Dolly SO, Kalaitzaki E, Puglisi M, Stimpson S, Hanwell J, Fandos SS, Stapleton S, Ansari T, Peckitt C, Kaye S, Lopez J, Yap TA, van der Graaf W, de Bono J, Banerji U.

Cancer. 2016 Sep 26. doi: 10.1002/cncr.30235. [Epub ahead of print]

4.

"I didn't really understand it, I just thought it'd help": exploring the motivations, understandings and experiences of patients with advanced lung cancer participating in a non-placebo clinical IMP trial.

Harrop E, Noble S, Edwards M, Sivell S, Moore B, Nelson A; FRAGMATIC Trial Management Group (TMG).

Trials. 2016 Jul 20;17(1):329. doi: 10.1186/s13063-016-1460-8.

5.

The role of therapeutic optimism in recruitment to a clinical trial in a peripartum setting: balancing hope and uncertainty.

Hallowell N, Snowdon C, Morrow S, Norman JE, Denison FC, Lawton J.

Trials. 2016 Jun 1;17(1):267. doi: 10.1186/s13063-016-1394-1.

6.

Study partners perform essential tasks in dementia research and can experience burdens and benefits in this role.

Black BS, Taylor HA, Rabins PV, Karlawish J.

Dementia (London). 2016 May 13. pii: 1471301216648796. [Epub ahead of print]

7.
8.

Ways of Hoping: Navigating the Paradox of Hope and Despair in Chronic Pain.

Eaves ER, Nichter M, Ritenbaugh C.

Cult Med Psychiatry. 2016 Mar;40(1):35-58. doi: 10.1007/s11013-015-9465-4.

9.

Confronting Therapeutic Failure: A Conversation Guide.

Morgans AK, Schapira L.

Oncologist. 2015 Aug;20(8):946-51. doi: 10.1634/theoncologist.2015-0050. Epub 2015 Jun 22. Review.

10.

"It is not guaranteed that you will benefit": True but misleading?

Kim SY, Wilson R, De Vries R, Kim HM, Holloway RG, Kieburtz K.

Clin Trials. 2015 Aug;12(4):424-9. doi: 10.1177/1740774515585120. Epub 2015 May 11.

11.
12.

Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?

Nicholson KA, Cudkowicz ME, Berry JD.

Neurotherapeutics. 2015 Apr;12(2):376-83. doi: 10.1007/s13311-015-0341-2. Review.

13.

American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.

Weber JS, Levit LA, Adamson PC, Bruinooge S, Burris HA 4th, Carducci MA, Dicker AP, Gönen M, Keefe SM, Postow MA, Thompson MA, Waterhouse DM, Weiner SL, Schuchter LM.

J Clin Oncol. 2015 Jan 20;33(3):278-84. doi: 10.1200/JCO.2014.58.2635. Epub 2014 Dec 15. No abstract available.

14.

Modes of hoping: understanding hope and expectation in the context of a clinical trial of complementary and alternative medicine for chronic pain.

Eaves ER, Ritenbaugh C, Nichter M, Hopkins AL, Sherman KJ.

Explore (NY). 2014 Jul-Aug;10(4):225-32. doi: 10.1016/j.explore.2014.04.004. Epub 2014 Apr 19.

15.

Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception?

Kim SY, De Vries R, Parnami S, Wilson R, Kim HM, Frank S, Holloway RG, Kieburtz K.

J Med Ethics. 2015 May;41(5):391-7. doi: 10.1136/medethics-2013-101987. Epub 2014 May 22.

16.

Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study.

Wright AA, Zhang B, Keating NL, Weeks JC, Prigerson HG.

BMJ. 2014 Mar 4;348:g1219. doi: 10.1136/bmj.g1219.

17.

Patients' understanding of how genotype variation affects benefits of tamoxifen therapy for breast cancer.

Brewer NT, Defrank JT, Chiu WK, Ibrahim JG, Walko CM, Rubin P, Olajide OA, Moore SG, Raab RE, Carrizosa DR, Corso SW, Schwartz G, Peppercorn JM, McLeod HL, Carey LA, Irvin WJ Jr.

Public Health Genomics. 2014;17(1):43-7. doi: 10.1159/000356565. Epub 2014 Jan 22.

18.

QUALZICE: a QUALitative exploration of the experiences of the participants from the ZICE clinical trial (metastatic breast cancer) receiving intravenous or oral bisphosphonates.

Nelson A, Fenlon D, Morris J, Sampson C, Harrop E, Murray N, Wheatley D, Hood K, Griffiths G, Barrett-Lee P.

Trials. 2013 Oct 9;14:325. doi: 10.1186/1745-6215-14-325.

19.

Clinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death.

Enzinger AC, Zhang B, Weeks JC, Prigerson HG.

J Pain Symptom Manage. 2014 Jun;47(6):1078-90. doi: 10.1016/j.jpainsymman.2013.07.004. Epub 2013 Oct 5.

20.

"Is a cure in my sight?" Multi-stakeholder perspectives on phase I choroideremia gene transfer clinical trials.

Benjaminy S, Macdonald I, Bubela T.

Genet Med. 2014 May;16(5):379-85. doi: 10.1038/gim.2013.148. Epub 2013 Sep 26.

Supplemental Content

Support Center